论文部分内容阅读
目的:评价酚妥拉明在毛细支气管炎合并心衰早期治疗中的应价值。方法:2013年1月~2014年12月,安医附院儿科2病区住院收治毛细支气管炎合并心衰120例,其中未给予酚妥拉明纳入对照组60例,给予酚妥拉明治疗60例纳入治疗组,对比相关指标。结果:治疗组症状缓解时间、湿罗音消失时间、住院天数低于对照组,差异具有统计学意义(P<0.05);治疗组治愈率86.67%、好转率11.67%、无效率1.67%,对照组则为78.33%、30.00%、8.33%,两组临床疗效差异无统计学意义(P>0.05)。结论:酚妥拉明用于毛细支气管炎合并心衰的早期治疗可加速患儿康复。
Objective: To evaluate the value of phentolamine in the early treatment of bronchiolitis with heart failure. METHODS: From January 2013 to December 2014, 120 patients with bronchiolitis and heart failure were enrolled in Department of Pediatrics 2, An Hospital Affiliated Hospital. Of them, 60 were not included in the control group, and were given phentolamine 60 cases were included in the treatment group, comparing the relevant indicators. Results: The symptom relief time, the disappearance time of wet rales and hospitalization days in the treatment group were lower than those in the control group (P <0.05). The cure rate of the treatment group was 86.67%, the improvement rate was 11.67% and the inefficiency rate was 1.67% Group was 78.33%, 30.00%, 8.33%, no significant difference in clinical efficacy between the two groups (P> 0.05). Conclusion: Phentolamine used for early treatment of bronchiolitis complicated with heart failure can accelerate the recovery of children.